This prize recognises the contribution of medical students in the completion of clinical audit, service transformation and small research projects in the field of gynaecological oncology. The application should be supported by a supervisor who is a BGCS member
Value of prize: £100
Number of awards per year: 7
Highest scoring proposals target:
Ovarian cancer
Endometrial cancer
Cervical cancer (including HPV-related disease)
Vulval/vaginal cancer
Rare gynaecological tumours
Indirect oncology with little gynecologic anchoring → low enthusiasm.
Panels consistently reward:
Earlier diagnosis
Improved staging accuracy
Reduced diagnostic delays
Surgical/operative decision support
Treatment toxicity reduction
Optimization of follow-up
Proposals must clearly articulate patient-facing impact.
BGCS grants are typically modest. Prior awardees succeed by:
Using existing infrastructure
Leveraging institutional datasets
Employing simple, targeted intervention studies
Massively scoped molecular projects are considered mis-aligned.
Reviewers respond positively to:
NHS pathway improvement
MDT workflow optimization
Guideline-aligned QI projects
Real-world observational cohorts
Connection to UK practice context is a powerful predictor.
A very common successful theme:
variations in care delivery
adherence to NICE/BGCS guidance
surgical outcome tracking
survivorship pathway optimization
Audits with prospective intervention → strong scores.
Well-scoring focus areas include:
sexual health outcomes
fertility preservation
psychological support models
follow-up burden reduction
Panels value person-centered oncology.
BGCS awards are intentionally friendly to:
trainees
junior faculty
surgeons-in-training
early clinical academics
Mentored proposals succeed disproportionately.
Successful projects often use:
retrospective cohort analytics
simple biomarker feasibility explorations
imaging refinement approaches
surgical decision support scoring
Ambitious omics screens without follow-up plans typically fail.
Prior awardees nearly always have:
senior consultant oversight
clinical academic supervision
letters supporting access to data/patients
Weak mentorship → reviewer concern.
BGCS places value on:
standardized care algorithms
equitable treatment access
audit-driven service redesign
Demonstrating variation → proposing remedy = high success likelihood.
Early detection pathways for ovarian cancer
HPV vaccination programme optimization
Sentinel node mapping refinement
Robotic surgical outcomes
Predictive toxicity monitoring
✘ Scope too large for award size
✘ Weak justification of gynecologic cancer specificity
✘ Little novelty (e.g., descriptive audits without intervention)
✘ No statistical plan / insufficient power
✘ Application appears duplicative or extension of existing funding
✘ Risk of poor recruitment feasibility
Aim 1 — Quantify care variation or diagnostic gap
Aim 2 — Implement targeted intervention / algorithm
Aim 3 — Evaluate improvement in measurable clinical endpoints
Two well-defined aims > three unfocused ones.
Successful PIs typically show:
a handful of specialty-relevant publications,
track record of QI or audit engagement,
oncology MDT involvement,
clinical workflow insight.
Prospective observational studies
Pragmatic clinical triallets
Audit → guideline-implementation → re-audit loops
Structured questionnaires with validated scales
Imaging modality comparative assessment
Good budgets:
cost-neutral analytics from existing data
modest biostatistics support
participant recruitment expenses
imaging/assay test fees
Reviewers dislike:
equipment purchases
vague consumable categories
general admin overhead
A competitive BGCS proposal is:
✅ small, focused, feasible
✅ clinically meaningful
✅ relevant to UK practice variation
✅ trainee-friendly / mentored
✅ anchored to measurable patient outcomes
✅ improvement-oriented, not merely descriptive
The majority of awards are for members of the BGCS only. Some specific awards are open to non-members. You must satisfy the criteria of the award at the time of application, not at the time of the award being given.
Eligible Countries:
Sponsor Institute/Organizations: British Gynaecological Cancer Society (BGCS)
Sponsor Type: Corporate/Non-Profit
Address: Consultant Gynaecological Surgeon, The Royal Marsden, London
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 31, 2025
Dec 31, 2025
$133
7 awards available. £100
Affiliation: British Gynaecological Cancer Society (BGCS)
Address: Consultant Gynaecological Surgeon, The Royal Marsden, London
Website URL: https://www.bgcs.org.uk/professionals/awards-grants-and-prizes/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.